##CancerImmunology
LightNews LightNews
imtadvances.bsky.social
🦠 DC3s in solid tumours can prime T cells and influence outcomes—boosting survival in some cancers, but promoting immunosuppression in others.

👉 https://bit.ly/3T2blRg
##Immunotherapy #CancerImmunology
November 7, 2025 at 11:10 AM
scverse.bsky.social
Meet the keynote speakers for the 2025 scverse conference!

Elham Azizi, Associate Professor of Cancer Data Research and Biomedical Engineering at Columbia University
🧵

@elhamazizi.bsky.social
@columbiauniversity.bsky.social

#scverse #scverse2025 #machinelearning #genomics #cancerimmunology
November 6, 2025 at 3:59 PM
nkinl.bsky.social
What a great recognition for our inspiring scientist and professor Karin de Visser: she received the Josephine Nefkens Prize 2025. Congratulations Karin! 🎉

#NKI #fundamentalresearch #cancerresearch #oncology #breastcancer #cancerimmunology
November 6, 2025 at 12:21 PM
irbbarcelona.org
Join us in our plenary #seminar this week, with Maria Tsoumakdou, MD PhD, from BSRC Alexander Fleming and National & Kapodistrian University of Athens University of Athens.

Host: Dr. @batllelab.bsky.social 

Register here ➡️ https://shorturl.at/HNwEM

#CancerResearch #CancerImmunology

🧪
October 6, 2025 at 9:02 AM
jaehyukchoimd.bsky.social
We have an active search for tenure-track faculty interested in #ImmuneEngineering #ProteinEngineering #GenomeEngineering & #CancerImmunology. Join the newly formed Center for Cellular Therapies and Cancer Immunology #CCTCI. Learn more at apply.interfolio.com/173562. #facultyjobs
Apply - Interfolio {{$ctrl.$state.data.pageTitle}} - Apply - Interfolio
apply.interfolio.com
September 20, 2025 at 12:48 AM
biomedizin.unibas.ch
Researchers @biomedizin.unibas.ch developed cartilage implants from nasal septum cells, and showed that allowing them to mature for two weeks improved outcomes. 🔬Congratulations to all contributors.
doi.org/10.1126/scit...

#Immunotherapy #CancerImmunology #FusionProtein #PD1IL2v #TCellTherapy
© Martin Oeggerli (www.Micronaut.ch) 2019-2025, with Marcel Philipp Trefny, and Prof. Alfred Zippelius, Cancer Immunology, University Hospital Basel, Pathology University Hospital Basel, and C-CINA, Biozentrum, University Basel
September 18, 2025 at 7:30 AM
imtadvances.bsky.social
Attending Cancer Immunology: Advances & Therapeutic Application?

Come and visit us at our booth to learn more about our journals, upcoming special collections, and opportunities to publish! #CancerImmunology #Immunology
September 10, 2025 at 11:15 AM
medchemexpress.bsky.social
🎁 Pick up exclusive MCE gifts and merch 🤩
Our team – Sona Allahverdiyeva, Elyès Aouadi, and Ahmed F. Ibrahim, MBA – will be on hand to share insights, answer questions, and collaborate on solutions tailored to your research needs.
#CICON2025 #CancerImmunology #MedChemExpress
September 9, 2025 at 8:17 AM
moloncology.bsky.social
🔍 We are looking for papers!

🤝 In conjunction with the @EACRnews conference on #ImmunoOncology we have an active call for papers!

📩 Submit your latest research in the field of #CancerImmunology #ImmunoOnc

👉 Find out more details buff.ly/ZDb3rO0
September 2, 2025 at 8:58 AM
scverse.bsky.social
Meet the keynote speakers for the 2025 scverse conference!

Elham Azizi, Associate Professor of Cancer Data Research and Biomedical Engineering at Columbia University
🧵

@elhamazizi.bsky.social
@columbiauniversity.bsky.social

#scverse #scverse2025 #machinelearning #genomics #cancerimmunology
August 28, 2025 at 3:04 PM
mpnrf.bsky.social
Cancer researchers are mobilizing the immune system against the CALR mutation in MPNs.  
  
 💉 Testing peptide vaccines
 🧬 Engineering mutant CALR-specific CAR T cells
 🧪 Developing bispecific antibodies

#CALRmutation #MPNresearch #Immunotherapy #RareCancer #CancerImmunology
August 15, 2025 at 1:31 PM
febsletters.bsky.social
🔬 What’s the role of dendritic cells in the tumor microenvironment? Explore DC subsets and new therapeutic strategies in cancer. Read more: febs.onlinelibrary.wiley.com/doi/10.1002/...
#CancerImmunology #DendriticCells #TumorMicroenvironment
August 12, 2025 at 12:11 PM
arxivlens.bsky.social
Conserved programs and specificities of T cells targeting hematological malignancies
Abelin, J. G., Boschert, T. et al.
Paper
Details
#TCellTherapy #HematologicalMalignancies #CancerImmunology
August 11, 2025 at 4:01 PM
discovimmunol.bsky.social
How do ILC1s help fight cancer, and what role does PD-1 play?

This open access review breaks down the complexity of ILC1 subsets and their checkpoint regulation.

📖 https://bit.ly/4fnU0N0

#ILC1 #CancerImmunology #PD1
August 11, 2025 at 9:50 AM
eanoassociation.bsky.social
A recent publication in @nature.com covers immunosuppressive astrocyte–glioma interactions identified through barcoded viral tracing.
🔗 www.nature.com/articles/s41...

#NeuroOncology #Glioma #CancerImmunology #BrainTumor #Nature #EANOessentials #medsky
Barcoded viral tracing identifies immunosuppressive astrocyte–glioma interactions - Nature
Using viral barcode tracing to detect interactions between glioblastoma cells and non-malignant astrocytes in patient samples, investigators discovered a pathway that reduces tumour-specific immunity ...
www.nature.com
August 1, 2025 at 3:38 PM
imtadvances.bsky.social
🔥 One of our most read articles!

Discover the unique role of DC3 dendritic cells in shaping immune responses within solid tumours and their impact on cancer therapy.

📖 Read more: https://bit.ly/3T2blRg

#CancerImmunology #DC3 #Immunotherapy
August 1, 2025 at 2:54 PM
calcinottolab.bsky.social
🚀 Excited to share our latest publication!
👉 www.nature.com/articles/s41...
A fantastic collaboration with an incredible team.

#BreastCancer #Neutrophils #TumorMicroenvironment #PARPinhibitors #DNARepair #NatureCommunications #CancerImmunology #CalcinottoLab
Tumor-associated neutrophil precursors impair homologous DNA repair and promote sensitivity to PARP inhibition - Nature Communications
Tumor-associated neutrophils exhibit heterogeneity in breast cancer. Here, the authors identify a distinct precursor population (PreNeu) in estrogen receptor-positive tumors. PreNeu suppress homologou...
www.nature.com
July 31, 2025 at 1:53 PM
amitava-immuno.bsky.social
First postdoc paper with @hannahvmeyer.bsky.social on #TCR cross-reactivity database & modeling out now in Cell Systems: doi.org/10.1016/j.ce...

BATCAVE database + Paper codes: github.com/meyer-lab-cs...

BATMAN + Tutorial Notebooks: github.com/meyer-lab-cs...

#ImmunoSky #T-cells #CancerImmunology
Alt Text: Infographic summarizing a study on T cell receptor (TCR) activation by mutant epitopes. The graphic is divided into three sections: Database (top panel): Describes a dataset with over 22,000 TCR-pMHC pairs, involving more than 150 activated TCRs and 25 mutagenized epitopes, covering both MHC class I and II, aggregated from 20+ years of experiments. A heatmap of epitope mutations and TCR structures is illustrated. Model (middle panel): Shows the BATMAN model for predicting TCR activation. The model combines an amino acid mutation similarity matrix with a learned mutation position weight profile and an MHC binding factor, outputting a prediction of TCR activation. Predictions (bottom panel): Highlights two applications — predicting tissue targets of cancer-specific TCRs and T cell responses to mutant viral antigens — accompanied by illustrative icons of organs, T cells, and viruses.
July 25, 2025 at 2:59 PM
msklibrary.bsky.social
Synapse: Your Connection to our MSK Authors
Meet: Marcel Hohl
Research Focus: Molecular Biology; Senior Research Scientist

Chronic interferon-stimulated gene transcription promotes oncogene-induced breast cancer

#BreastCancerResearch #OncogeneActivation #GeneTranscription #CancerImmunology
July 23, 2025 at 4:43 PM
febsletters.bsky.social
⚔️ T cells vs. B-cell tumors—who wins? Single-cell technology elucidates roles in pathogenesis, progression, and therapeutic response 💊 febs.onlinelibrary.wiley.com/doi/10.1002/...
#CancerImmunology #SingleCell #Lymphoma
July 22, 2025 at 9:02 AM
moloncology.bsky.social
🔍 We are looking for papers!

🤝 In conjunction with the recent @EACRnews conference on #ImmunoOncology we have an active call for papers!

📩 Submit your latest research in the field of #CancerImmunology #ImmunoOnc

🖊️ Research Article, Short Report or Method

👉 Find out more details buff.ly/ZDb3rO0
July 21, 2025 at 8:42 AM
drjonlim.bsky.social
🧑‍🔬Fantastic postdoc opportunity on an exciting project developing TCR-T for clear cell renal cell cancer with @turajliclab.bsky.social at @crick.ac.uk in London 🇬🇧.

Don’t miss out - deadline 23 July 2025!

#CancerImmunology
#TranslationalResearch

crick.wd3.myworkdayjobs.com/External/job...
Postdoctoral Fellow
Salary for this Role: From £45,500 per annum plus benefits, subject to skills and experience Job Title: Postdoctoral Fellow Reports to: Samra Turajlic [C] Closing Date: 23/Jul/2025 23.59 GMT Job Descr...
crick.wd3.myworkdayjobs.com
July 16, 2025 at 9:05 PM
drjonlim.bsky.social
Very proud of @giampazolias.bsky.social who has just been awarded the prestigious 2025 BACR/AstraZeneca Young Scientist Frank Rose Award 🏆.

#CancerImmunology
#CancerResearch

#TeamManchester 🐝
@cruk-mi.bsky.social
@mcrcnews.bsky.social
giampazolias.bsky.social Evangelos Giampazolias @giampazolias.bsky.social · Jul 15
I'm deeply honoured to receive the BACR/AstraZeneca Young Scientist Frank Rose Award in recognition of my cancer research.
Grateful to @thebacr.bsky.social @astra-zeneca.bsky.social ‬ #Mentors & #Colleagues whose support has shaped this journey.

My reflections👇
🔗 www.bacr.org.uk/news/2025-ba...
July 15, 2025 at 3:24 PM
tceliaterrassa.bsky.social
We’re thrilled to share our latest publication in
@cp-cancercell.bsky.social and very proud of C. Rozalén for this tour de force uncovering how TIM3⁺ breast cancer cells drive immune evasion during micrometastasis. #CancerImmunology #BreastCancer #Metastasis www.cell.com/cancer-cell/...
TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak
Rozalén et al. report that TIM3 in breast cancer drives a specific mechanism of immune escape during micrometastasis. TIM3+ tumor cells exhibit stemness/EMT features and promote immune-evasion by indu...
www.cell.com
July 10, 2025 at 3:19 PM
milaboratories.bsky.social
🔬 Why do some cancer patients respond to cell therapy while others don't?

We’re excited to answer this question in our next webinar: Decoding Adoptive Cell Therapy Response with ImmuneWatch.

Register here: shorturl.at/063UV

#CancerImmunology #AdoptiveCellTherapy #SingleCell #CellTherapy
July 3, 2025 at 2:04 PM